| Trial ID: | L0915 |
| Source ID: | NCT00427037
|
| Associated Drug: |
Cholecalciferol
|
| Title: |
Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00427037/results
|
| Conditions: |
Chronic Kidney Disease|Vitamin D Deficiency
|
| Interventions: |
DRUG: Cholecalciferol|DRUG: Placebo
|
| Outcome Measures: |
Primary: 25-hydroxyvitamin D, 25-hydroxyvitamin D measured in serum by ELISA, 3 months | Secondary: Bone Turnover Marker-CTX, Blood levels of C-telopeptide, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Atlanta VA Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
34
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-12
|
| Completion Date: |
2013-03
|
| Results First Posted: |
2009-03-12
|
| Last Update Posted: |
2015-07-22
|
| Locations: |
Emory Clinic, Atlanta, Georgia, 30322, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00427037
|
